Here, we report the crystal structure of a cancer-derived MEK1 mutant, and demonstrate the molecular mechanisms underlying abnormal kinase activities of the cancer- and RASopathy-associated MEK1 mutants. The gene discussed is MAP2K1; the disease is cancer.